Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Pacemaker CE mark with options for magnetic resonance imaging (MRI)

Boston Scientific : 26 October, 2014  (Company News)
Boston Scientific Corporation has received CE Mark approval for the Accolade pacemaker family. When implanted with the company's Ingevity leads, Accolade pacemakers enable patients to receive full-body MRI scans in both 1.5 Tesla and 3.0 Tesla systems. In addition, the Boston Scientific ImageReady technology offers flexible MRI option, allowing higher energy scan sequences, featuring a programmable MRI timer designed to improve patient workflow.
Pacemaker CE mark with options for magnetic resonance imaging (MRI)

The first Accolade device implant was performed by a team coordinated by Prof Francesco Romeo, Director of the Cardiology Department of Fondazione Policlinico Tor Vergata, Rome, and President-Elect of Italian Society of Cardiology (SIC). "Thanks to the Accolade pacemaker family, I can offer my patients the best pacing therapies while giving them unparalleled access to imaging," said Romeo. "Additionally, the full suite of diagnostics and the excellent longevity of the device mean that I should be able to utilise the device for my patients undergoing MRI scans in the future – many years from now."


 


In addition to the CE mark approval and launch of the Accolade pacemaker family, Boston Scientific received CE Mark approval for the Visionist and Valitude CRT-Ps with quadripolar pacing technology. When paired with the Acuity X4 pacing leads, these systems offer many options to reach and pace the target location in the left ventricle, potentially improving the patient response to CRT therapy.


 


Dr Stuart Harris, Clinical Director of the Essex Cardiothoracic Centre, Basildon, UK, performed the first implant of the Visionist X4 system. 


 


"We have prioritized investments and now have the first and only subcutaneous ICD, the smallest ICD, and the longest-lasting pacemaker, ICD and CRT devices in the world," said Joe Fitzgerald, executive vice president and president, Rhythm Management. "Now, with the Accolade pacemaker family, we also offer the most flexible MRI conditional pacemaker system, along with advanced diagnostics that assist physicians in detecting atrial arrhythmias. We believe that the provision of automatic daily monitoring and advanced diagnostics to our pacemaker devices will help physicians identify atrial fibrillation sooner, enabling them to initiate patient anti-coagulation therapy to reduce the risk of stroke."


                                         


In addition, Boston Scientific is actively pursuing MRI compatibility for its existing implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy defibrillators (CRT-D), including the Autogen, Dynagen, Inogen and Origen CRT-Ds and lead technologies such as the Ingevity, Reliance and Acuity leads.



  • Accolade, Visionist, Valitude, Autogen, Origen, Ingevity and Acuity X4 devices are not available for sale in the US.



 

Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo